Sign Up to like & get
recommendations!
0
Published in 2019 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noz126.217
Abstract: Immune check-point blockade targeting programmed cell death ligand-1 (PD-L1)/programmed death-1 (PD-1) axis has created paradigm shift in the treatment of advanced cancer. The prognosis of the ‘ST-RELA’ and ‘PF-A’ molecular subgroups of ependymomas (EPN) remains…
read more here.
Keywords:
rela;
molecular subgroups;
subgroups ependymomas;
epns ... See more keywords